Literature DB >> 18427091

Traumatic brain injury: can the consequences be stopped?

Eugene Park1, Joshua D Bell, Andrew J Baker.   

Abstract

Traumatic brain injury is a leading cause of morbidity and death in both industrialized and developing countries. To date, there is no targeted pharmacological treatment that effectively limits the progression of secondary injury. The delayed progression of deterioration of grey and white matter gives hope that a meaningful intervention can be applied in a realistic timeframe following initial trauma. In this review we discuss new insights into the subcellular mechanisms of secondary injury that have highlighted numerous potential targets for intervention.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18427091      PMCID: PMC2292762          DOI: 10.1503/cmaj.080282

Source DB:  PubMed          Journal:  CMAJ        ISSN: 0820-3946            Impact factor:   8.262


  90 in total

1.  Treatment of ischemic brain damage by perturbing NMDA receptor- PSD-95 protein interactions.

Authors:  Michelle Aarts; Yitao Liu; Lidong Liu; Shintaro Besshoh; Mark Arundine; James W Gurd; Yu-Tian Wang; Michael W Salter; Michael Tymianski
Journal:  Science       Date:  2002-10-25       Impact factor: 47.728

2.  Surveillance for traumatic brain injury deaths--United States, 1989-1998.

Authors:  Nelson Adekoya; David J Thurman; Dionne D White; Kevin W Webb
Journal:  MMWR Surveill Summ       Date:  2002-12-06

Review 3.  Ischemia and stroke.

Authors:  Matthias Endres; Ulrich Dirnagl
Journal:  Adv Exp Med Biol       Date:  2002       Impact factor: 2.622

4.  Acute subdural hematoma and diffuse axonal injury in fatal road traffic accident victims: a clinico-pathological study of 15 patients.

Authors:  Sebastião Nataniel Silva Gusmão; José Eymard Homem Pittella
Journal:  Arq Neuropsiquiatr       Date:  2003-10-28       Impact factor: 1.420

Review 5.  Mitochondrial permeability transition: a common pathway to necrosis and apoptosis.

Authors:  Jae-Sung Kim; Lihua He; John J Lemasters
Journal:  Biochem Biophys Res Commun       Date:  2003-05-09       Impact factor: 3.575

Review 6.  Patient age and outcome following severe traumatic brain injury: an analysis of 5600 patients.

Authors:  Chantal W P M Hukkelhoven; Ewout W Steyerberg; Anneke J J Rampen; Elana Farace; J Dik F Habbema; Lawrence F Marshall; Gordon D Murray; Andrew I R Maas
Journal:  J Neurosurg       Date:  2003-10       Impact factor: 5.115

7.  NMDA receptor activation contributes to a portion of the decreased mitochondrial membrane potential and elevated intracellular free calcium in strain-injured neurons.

Authors:  Syed M Ahmed; John T Weber; Shi Liang; Karen A Willoughby; Heather A Sitterding; Beverly A Rzigalinski; Earl F Ellis
Journal:  J Neurotrauma       Date:  2002-12       Impact factor: 5.269

8.  Enhanced vulnerability to NMDA toxicity in sublethal traumatic neuronal injury in vitro.

Authors:  Mark Arundine; Gopal K Chopra; Andrew Wrong; Saobo Lei; Michelle M Aarts; John F MacDonald; Michael Tymianski
Journal:  J Neurotrauma       Date:  2003-12       Impact factor: 5.269

9.  Preinjury administration of the calpain inhibitor MDL-28170 attenuates traumatically induced axonal injury.

Authors:  A Buki; O Farkas; T Doczi; J T Povlishock
Journal:  J Neurotrauma       Date:  2003-03       Impact factor: 5.269

Review 10.  Protein accumulation in traumatic brain injury.

Authors:  Douglas H Smith; Kunihiro Uryu; Kathryn E Saatman; John Q Trojanowski; Tracy K McIntosh
Journal:  Neuromolecular Med       Date:  2003       Impact factor: 3.843

View more
  91 in total

1.  Computational modeling of axonal microtubule bundles under tension.

Authors:  Stephen J Peter; Mohammad R K Mofrad
Journal:  Biophys J       Date:  2012-02-21       Impact factor: 4.033

2.  Alterations of Parenchymal Microstructure, Neuronal Connectivity, and Cerebrovascular Resistance at Adolescence after Mild-to-Moderate Traumatic Brain Injury in Early Development.

Authors:  Maxime Parent; Ying Li; Vijayalakshmi Santhakumar; Fahmeed Hyder; Basavaraju G Sanganahalli; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2018-08-13       Impact factor: 5.269

3.  Cardiolipin-Dependent Mitophagy Guides Outcome after Traumatic Brain Injury.

Authors:  Honglu Chao; Chao Lin; Qiang Zuo; Yinlong Liu; Mengqing Xiao; Xiupeng Xu; Zheng Li; Zhongyuan Bao; Huimei Chen; Yongping You; Patrick M Kochanek; Huiyong Yin; Ning Liu; Valerian E Kagan; Hülya Bayır; Jing Ji
Journal:  J Neurosci       Date:  2019-01-09       Impact factor: 6.167

4.  Reduction of cerebral edema after traumatic brain injury using an osmotic transport device.

Authors:  Devin W McBride; Jenny I Szu; Chris Hale; Mike S Hsu; Victor G J Rodgers; Devin K Binder
Journal:  J Neurotrauma       Date:  2014-10-14       Impact factor: 5.269

5.  Beneficial Effects of Kaempferol after Developmental Traumatic Brain Injury Is through Protection of Mitochondrial Function, Oxidative Metabolism, and Neural Viability.

Authors:  Jyothsna Chitturi; Vijayalakshmi Santhakumar; Sridhar S Kannurpatti
Journal:  J Neurotrauma       Date:  2019-01-08       Impact factor: 5.269

6.  Stretch injury selectively enhances extrasynaptic, GluN2B-containing NMDA receptor function in cortical neurons.

Authors:  Carrie R Ferrario; Blaise O Ndukwe; Jianhua Ren; Leslie S Satin; Paulette B Goforth
Journal:  J Neurophysiol       Date:  2013-04-10       Impact factor: 2.714

Review 7.  Hyperphosphorylated tau is implicated in acquired epilepsy and neuropsychiatric comorbidities.

Authors:  Ping Zheng; Sandy R Shultz; Chris M Hovens; Dennis Velakoulis; Nigel C Jones; Terence J O'Brien
Journal:  Mol Neurobiol       Date:  2013-12-10       Impact factor: 5.590

8.  Incretin mimetics as pharmacologic tools to elucidate and as a new drug strategy to treat traumatic brain injury.

Authors:  Nigel H Greig; David Tweedie; Lital Rachmany; Yazhou Li; Vardit Rubovitch; Shaul Schreiber; Yung-Hsiao Chiang; Barry J Hoffer; Jonathan Miller; Debomoy K Lahiri; Kumar Sambamurti; Robert E Becker; Chaim G Pick
Journal:  Alzheimers Dement       Date:  2014-02       Impact factor: 21.566

9.  Neuroprotective effects of IGF-I following kainic acid-induced hippocampal degeneration in the rat.

Authors:  Panagiota Miltiadous; Antonios Stamatakis; Fotini Stylianopoulou
Journal:  Cell Mol Neurobiol       Date:  2009-09-24       Impact factor: 5.046

Review 10.  The need for new approaches in CNS drug discovery: Why drugs have failed, and what can be done to improve outcomes.

Authors:  Valentin K Gribkoff; Leonard K Kaczmarek
Journal:  Neuropharmacology       Date:  2016-03-12       Impact factor: 5.250

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.